The widely expressed adaptor protein Shb has previously been reported to contribute to T cell function due to its association with the T cell receptor and furthermore, several of Shb's known interaction partners are established regulators of blood cell development and function.
Introduction
The maintenance of the hematopoietic system throughout adult life requires a continuous generation of blood cells, a process dependent on a rare population of cells residing in the bone marrow, the long-term hematopoietic stem cells (LT-HSCs) [1] . Under steady state conditions the vast majority of LT-HSCs are found in the G 0 stage of the cell cycle [2, 3] . Hematopoietic stress in the form of cytotoxic injury [4] , blood loss [5] or stem cell stimulating cytokines [6] can however elicit an extensive proliferative response within the LT-HSC pool.
A strict regulation of the cell cycle is of utmost importance for LT-HSC and it has been extensively studied in animal knockout models. There is a fine balance between quiescence and maintaining sufficient proliferation to sustain hematopoiesis. Small shifts in the proliferative rates have been revealed to set off the system by exhaustion or reduced productivity. For instance, deletion of the cell cycle regulator p27 [7, 8] leads to increases in numbers of cycling cells and quickly depletes the system due to proliferative exhaustion of LT-HSC and hematopoietic progenitor (HPC) populations.
c-Kit and its ligand Stem Cell Factor (SCF), together with other hematopoietic cytokines, are well established regulators of LT-HSC quiescence and proliferation [9] .
Nonetheless, many of the intracellular signaling pathways that govern the maintenance of the LT-HSC pool remain unknown. Recently, several reports have implicated members of the Rho GTPase family as important for the control of hematopoiesis [10, 11] . Disruption of Rac signaling results in reduced proliferation of LT-HSC and selective Rac2 deletion leads to a failure to up-hold hematopoiesis under steady state conditions [10, 11] . Since focal adhesion kinase (FAK) has been shown to regulate Rac activity [12] , this signaling intermediate may also be of significance in this context. Shb is a widely expressed Src homology-2 domain containing adaptor protein [13, 14] established as a regulator of reproduction [15] , glucose homeostasis [16] , angiogenesis [17] and T cell function [14, 18, 19] . Notably, Shb has also been found to regulate the cell cycle in the pancreas and blood system in a cell type dependent manner. For example, overexpression of Shb promotes proliferation in endothelial cells and in neonatal pancreatic β-cells [20] .
Conversely, the loss of Shb expression results in elevated proliferative responses in T lymphoid cells to stimulation by CD3 and CD28 [19] .
Shb participates in the regulation of a number of pathways also known to impact development, and does this primarily through interactions with its functional domains. The Cterminal SH2-domain of Shb [20] facilitates interactions with receptor tyrosine kinases such as vascular endothelial growth factor receptor-2 (VEGFR-2) [21] , platelet derived growth factor receptor (PDGFR) [22] and the T cell receptor (TCR) [18, 23] . Moreover, Shb associates via its other domains with additional signaling elements such as SH2 domaincontaining leukocyte protein of 76 kDa (Slp76) [23] , Vav1 [23] , c-Abl [24] , FAK [17] , phospholipase C-γ (PLCγ), Src, and phosphatidylinositol-3 kinase (PI3K), acting as a scaffold in signaling cascades [20] . Several of Shb's known interaction partners, including PDGFR [25] , TCR [26] , Vav1 [27] , and FAK [28] , are established regulators of blood cell development and function. In addition, Shb deficient embryonic stem cells displayed reduced blood cell colony formation upon differentiation in vitro [29] . Thus, disruption of Shb mediated signaling could be hypothesized to result in a hematopoietic phenotype.
Utilizing the Shb knockout mouse [30] , we find in the current study reduced bone marrow cell responsiveness to SCF-stimulation and elevated basal activity with respect to the FAK/Rac1/p21-activated kinase (PAK) signaling axis [11, 28, 31] , proliferation defects in LT-HSCs during homeostasis, and an impairment in the long-term myeloid repopulating capacity of LT-HSCs. Unexpectedly, Shb is dispensable for stress hematopoiesis, and its loss results in diminished myelodepression in a non-competitive hematopoietic environment after genotoxic stress.
Materials and Methods

Experimental animals
The generation of Shb knockout mice has been described previously [30] . The animals were maintained on a mixed background (129Sv/C57Bl6/FVB) as no Shb-/-offspring was generated on the C57Bl/6 strain, or on the Balb/c background in which Shb-/-pups were born.
C57Bl/6 CD45.1 and Balb/c CD45.1 were from the Jackson Laboratory (Bar Harbor, ME).
All experiments were approved by the local animal ethics committees at Uppsala University.
Flow cytometric analysis and sorting of bone marrow and peripheral blood
Iliac bones, femurs and tibias were collected from 8 to 10 weeks old mice for all analyses. The bones were crushed and passed over a 70 µm cell strainer (BD Bioscience, Franklin Lakes, NJ) in order to obtain single-cell suspensions. The cells were stained for lineage markers with rat anti-mouse antibodies directed against CD4, B220, Mac-1, Gr-1, CD19 (Invitrogen, Carlsbad, CA), CD3 and CD8 (eBioscience, Hartfield, UK) followed by incubation with a PE-Cy5.5-conjugated goat anti-rat IgG (Invitrogen). Bone marrow cells were subsequently positively selected for c-Kit expression by magnetic separation with anti-cKit microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany), following the manufacturer's instructions. The c-Kit purified cells were further stained for CD34-FITC, cKit-APC-eFluor 780, CD41-PE, CD48-PE (eBioscience), CD150-PE-Cy7, CD105-Biotin, Sca-1-APC (BioLegend, San Diego, CA), Streptavidin Alexa Fluor 680 (Invitrogen) and Flk-2-PE (BD Bioscience) in order to identify the LT-HSC, MPP (multi-potent progenitor), GMP (granulocyte-monocyte progenitor) and MEP (megakaryocyte-erythroid progenitor) populations respectively. Peripheral blood was collected by retroorbital sampling in 0.05 mM EDTA (Merck, Whitehouse Station, NJ) and red blood cells were removed by sedimentation in 6% (w/v) Dextran T500 (GE Healthcare, Hemel Hempstead, UK) followed by lysis in Red cell lysis buffer (Sigma Aldrich, St. Louis, MO). The cells were subsequently stained with rat antimouse antibodies for the different lineages; CD4, CD8, CD3, B220, CD19, Gr-1 and Mac-1 and thereafter incubated with goat anti-rat PE-Cy5.5. For analysis of peripheral blood chimerism after transplantation the cells were also stained with CD45.1-FITC and CD45.2-APC (BD Bioscience).
In order to monitor FAK activity in LT-HSCs, bone marrow was isolated and promptly fixed in 4% paraformaldehyde. Cell surface staining to identify LT-HSCs was thereafter performed as described above. The cells were subsequently permeabilized with BD Cytoperm Buffer (BD Bioscience) and stained with phospho-FAK antibody (Invitrogen) followed by incubation with a PE-conjugated donkey anti-rabbit antibody (eBioscience). 
Cell cycle analysis of HSC and HPCs
DNA synthesis was determined with Hoechst 33342 (Invitrogen) staining and assessment of 5-bromo-2'-deoxyuridine (BrdU) incorporation. Briefly, mice (8-10 weeks of age) were given intraperitoneal injections with 2mg of BrdU (BD Bioscience). Bone marrow was isolated 1 hour after the injections and cells were surface stained as described in the previous section. Cell fixation and permeabilization was thereafter carried out using the BD Cytofix/Cytoperm kit (BD Bioscience) following the manufacturer's instruction. This was followed by DNase (300 µg/ml) treatment for 1 hour at 37°C and then by incubation with anti-BrdU-PE (BD Bioscience). To enable identification of different cell cycle stages the cells were stained with 1 µg/ml Hoechst 33342 for 10 minutes.
Cell cycle status was also determined using the RNA binding dye Pyronin Y (Sigma Aldrich) at a concentration of 0.5 µg/ml in combination with Hoechst (10 µg/ml). In short, bone marrow was stained as previously described to enable identification of HSC-and hematopoietic progenitor cell (HPC) populations. The cells were thereafter fixed and permeabilized and subsequently stained with Hoechst for 15 minutes, Pyronin Y was added during the final 10 minutes. 
Single-cell proliferation assay
CD150 + c-Kit + CD34 -Flk2 -CD41 -CD48 -Lin -LT-
LT-HSC transplantation
Competitive transplantations with LT-HSCs and 200 000 CD45. in order to ablate endogenous bone marrow. The recipients were retroorbitally bled at 6 or 16
weeks to monitor donor contribution to peripheral blood lineages.
Statistical analysis
Data is presented as mean ± Standard error of the mean (SEM). For comparison of difference between two groups with normal distributed data, unpaired Students t-tests were used unless otherwise stated. For paired comparisons, one wild type and one age and sex matched knockout sample was analyzed simultaneously, under identical conditions, and the wild type and the knockout values were set as one observation each for the comparison.
Comparisons between more than two groups were made by ANOVA, followed by Fischer's LSD. For comparison of proliferation potential to in vitro stimulation with cytokines Chisquare test was used. All p-values less than 0.05 were considered statistically significant.
Results
Deletion of Shb results in reduced proportions of LT-HSCs
Ablation of Shb expression has been found previously to result in decreased numbers of lymphocytes and monocytes in the peripheral blood [19] . (Fig. 1B, C, D). We also examined the LT-HSC compartment of Shb null mice bred onto the Balb/c background. LT-HSCs from Balb/c mice are known to express reduced levels of Sca-1 [39] and a different immunophenotypic definition was therefore utilized to identify LT-HSCs in Balb/c bone marrow. Instead of characterizing LT-HSCs by Sca-1, Flk2, CD41, and CD48
were introduced and LT-HSCs were subsequently defined as CD150 + c-Kit
-Lin -LT-HSCs (henceforth referred to as LT-HSC2) [33, 40, 41] . Flow cytometric analysis revealed reduced numbers of LT-HSC2s in Shb knockout bone marrow from Balb/c mice compared to wild type samples ( Fig. 2A, B) , indicating that the hematopoietic defect was not strain specific. These data suggest that Shb function is dispensable for homeostasis of progenitors but point to an important role for Shb in the maintenance and expansion of LT-HSC numbers.
Shb exerts control over HSC cell cycle progression
In order to address whether the deficiency of LT-HSCs in Shb knockout bone marrow was due to aberrant regulation of proliferation, DNA synthesis was evaluated in LT-HSCs and HPCs by BrdU incorporation. Bone marrow was isolated 1 hour after BrdU delivery, and
BrdU incorporation and Hoechst 33342 staining was assessed in order to ascertain proliferation rates. A reduction in total BrdU labeling suggested that Shb knockout LT-HSCs proliferate to a lesser extent than their wild type counterparts (Fig. 3A, B) . In addition, Shb deficiency resulted in significantly decreased BrdU labeling in the MPP population (Fig. 3A, C (Fig 3D and F) . Additionally, the LT-HSC proliferative response in vitro to a defined set of hematopoietic cytokines was evaluated in a single-cell proliferation assay, revealing a reduced ability among individual Shb knockout LT-HSC2s to give rise to colonies (S. LT-HSCs promptly responded by entering the cell cycle at frequencies similar to those observed in wild type controls, both 3 and 5 days after 5-FU treatment (Fig. 4A) . The proliferative response to hematopoietic stress did therefore not appear to be affected by loss of Shb function.
Stress hematopoiesis is unaffected by the loss of Shb
Additionally, as 5-FU is known to efficiently cause depletion of myeloid cells in circulation, the peripheral blood myeloid profile was therefore monitored after treatment.
Wild type mice exhibited the expected, gradual myelodepression, with statistically significant reduced relative numbers of myeloid cells on day 5 when compared to untreated animals ( Fig.   4B ). Shb deficient myeloid cells were not equally affected by the 5-FU treatment, as the reduction in their numbers was less pronounced and failed to reach significance.
Altered signaling characteristics in Shb knockout bone marrow cells
The receptor tyrosine kinase c-Kit and its ligand SCF together establish a critical signaling cascade that protects LT-HSC and HPC viability [9] . (Fig 5A) .
Shb interacts with FAK and loss of Shb has been demonstrated to affect FAK signaling in response to VEGF [17] . FAK signaling was therefore estimated revealing an elevated phosphorylation at an activating site (Y397) in the absence of SCF stimulation in Shb null samples and failure of SCF to activate FAK further (Fig. 5B) . The Rho family GTPase Rac1 is regulated by FAK [12] . Rac1 also displayed a significantly increased activity under basal conditions in Shb knockout cells, as indicated by the elevated levels of GTP-bound Rac1 (Fig.   5C ). Found immediately downstream of Rac1 is the PAK family of serine/threonine kinases.
PAK signaling also appeared aberrant in Shb knockout bone marrow with significantly increased basal phosphorylation levels as well as a lack of stimulation effect after addition of SCF in knockout samples (Fig. 5D ).
To determine the activity of FAK in LT-HSCs, bone marrow was fixed and stained for pY Y397 -FAK, as well as for cell surface markers defining this cell population and subsequently analyzed by FACS. Shb deficient LT-HSCs displayed a significant increase in phospho-FAK levels indicating an aberration of FAK signaling not only in c-Kit + bone marrow cells but also within the LT-HSC cell population (Fig. 6A-C ). An attempt was also made to stain for pPAK but a robust signal could not be obtained using this mode of analysis.
Overall, the data implied that loss of Shb deregulated the FAK/Rac1/PAK signaling cascade resulting in elevated basal activation and a failure to mount a ligand-stimulated response of this pathway. Signaling through FAK/Rac1/PAK has been implicated in LT-HSC and HPC cell cycle control, thus providing a mechanistic explanation for the observed differences in the LT-HSC cell cycle [10, 11, 28, 31, 43] .
To directly assess the importance of elevated FAK activity for Shb knockout LT-HSC proliferation, mice were treated with a FAK inhibitor prior to sacrifice, LT-HSCs were singlecell sorted and cell proliferation determined in proliferation assays (Fig. 6D) . Shb knockout LT-HSCs exhibited a higher proliferative ability after FAK-inhibition compared with untreated cells and the number of proliferating LT-HSCs after FAK inhibition was similar to that of the corresponding wild-type cells. FAK-activity was decreased in the Shb knockout LT-HSCs (Fig. 6E ) whereas no major effect was noticed in the wild-type situation (results not shown). The data confirm the notion that the altered signaling characteristics of Shb knockout LT-HSCs result in reduced proliferation.
Reduced long-term repopulating activity of Shb knockout LT-HSCs
The principal role of LT-HSC and HPC is their ability to reconstitute the blood system, and repopulation of lethally irradiated recipients provides the best measure of evaluating this function [1] . By transplanting purified LT-HSCs together with unfractionated bone marrow as competition, the transplanted cells are stimulated to proliferate at an accelerated rate. In the current study, two isoforms of CD45, CD45.1 and CD45.2, were used to distinguish between donors and competitors. As previously indicated, the Shb knockout was initially maintained on a mixed genetic background consisting of FVB, C57Bl/6 and Sv129. Balb/c and C57Bl/6 are the two primary strains available as CD45.1 carriers and consequently we decided to perform competitive LT-HSC transplantations using Shb null mice bred onto the Balb/c background since Shb -/-mice cannot be obtained on the C57Bl/6
background [30] .
Lethally irradiated CD45.1 + Balb/c recipients were subsequently injected with either 20 sorted (S. Fig. 3 ) WT or KO LT-HSC2s each together with 200000 competitors.
Engraftment appeared largely unaffected in the absence of Shb in Balb/c recipients 6 weeks after the transplantation (Fig. 7A) . At 16 weeks, engraftment of all three lineages (myeloid, B cell and T cell) from donor LT-HSC2 cells was observed, confirming the notion that this cell population purified from Balb/c mice indeed contains LT-HSCs. However, when chimerism was determined at 16 weeks, there was a significant decrease in the proportions of donor-derived cells in the myeloid lineage of Shb null recipients whereas the B and T cell lineages appeared unaffected (Fig. 7A, S. Fig. 4 ). Between week 6 and 16, the ratio of CD45.2 + cells would be expected to increase as the pool of transplanted LT-HSCs gradually expand their numbers to replenish the blood system; therefore, the difference in chimerism within the myeloid lineage between 6 and 16 weeks after the LT-HSC2 transplantation was determined.
Wild type recipients displayed a 3-fold higher increase in the ratio of CD45. constrain adult LT-HSC maintenance [48] . We presently note that Shb knockout bone marrow exhibits several signaling defects in FAK, Rac1 and PAK signaling with elevated basal activity and reduced responsiveness to SCF stimulation.
FAK is highly expressed in LT-HSCs but due to the embryonic lethality of FAK knockouts little is known about its effects on the hematopoietic system [28, 43] . Conditional deletion of FAK in bone marrow has revealed extensive but opposing effects on proliferation in hematopoietic progenitor populations [28, 49] . Erythroid progenitors from FAK null mice displayed decreased proliferative responses to SCF stimulation [28] . In a population of FAK deficient KLS cells that primarily corresponded to multi-potent progenitors, a larger fraction of cells was found to be actively cycling [49] , suggesting that the effect of FAK signaling is highly dependent on which hematopoietic cell type is observed. Shb knockout c-Kit + bone marrow cells as well as LT-HSCs exhibited significant hyperphosphorylation of FAK in the absence of stimulation suggesting that the proliferative defect could be effected by elevated FAK signaling. This notion was confirmed by assessing LT-HSC proliferation after FAK inhibition using a single-cell proliferation assay. An important downstream effector of FAK activity is Rac1 [12] . Western blot analysis of c-Kit + cells also revealed elevated levels of active Rac1 and its immediate downstream target PAK in Shb deficient cells under basal conditions. Rac1 has been implicated as an important regulator of LT-HSC and HPC cell cycle progression [11] . In addition, PAK has been demonstrated to regulate proliferation in several different hematopoietic lineages including mast cells and T cells [50, 51] and PAK hyperactivation was recently linked to elevated LT-HSC proliferation in CD48 null mice [31] . 
